Effective date
Medicare changes effective August 10, 2026
5 CMS and MAC policy updates take effect on this date across 5 MAC jurisdictions. Every entry links to the government document it came from.
Medicare LCD · 4
- LCD L40272 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — WPS
LCD-L40272WPSClinical Laboratorysource ↗
- LCD L40199 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — CGS Administrators
LCD-L40199CGS AdministratorsClinical Laboratorysource ↗
- LCD L40197 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — Noridian
LCD-L40197NoridianClinical Laboratorysource ↗
- LCD L40187 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — Palmetto GBA
LCD-L40187Palmetto GBAClinical Laboratorysource ↗
CMS Transmittal · 1
- CMS Transmittal R13856MSP: ECRS Update for Prescription Drug Inquiries (PDIs) to Prevent the Creation of Records with…
CMS-T-R13856MSPNationalMulti-specialtysource ↗